<DOC>
	<DOCNO>NCT02923037</DOCNO>
	<brief_summary>This pilot clinical trial study Hatha yoga reduce physical emotional problem breast cancer survivor stage II-III lymphedema . Yoga practice may benefit breast cancer survivor lymphedema directly support lymph transport ( posture , breathing , relaxation ) emotional well-being ( relaxation , meditation ) .</brief_summary>
	<brief_title>Hatha Yoga Breast Cancer Survivors</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine feasibility modify yoga program breast cancer survivor ( BCS ) lymphedema . II . To identify document require modification safe feasible practice . III . To obtain recruitment estimate determine barrier recruitment ( acceptability ) . IV . To evaluate implementation fidelity ( adherence competence ) barrier implementation fidelity . V. To establish safety . VI . To assess satisfaction . VII . To determine preliminary efficacy modify yoga program lymphedema BCS , associate physical psychological symptoms/symptom burden , overall health status . OUTLINE : Patients undergo initial yoga evaluation 60 minute . Patients undergo first guide yoga practice session 30-60 minute subsequent guide yoga session 30-90 minute . 3 time week 4 week , twice week additional 4 week . Patients also encourage complete home yoga practice 30 90 minute every day 8 week .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lymphedema</mesh_term>
	<criteria>Lymphedema , symptomatic stage II III &gt; 3 month ( mths ) postbreast cancer treatment No active cancer Has compression sleeve Ability understand English order complete questionnaire Willing guide home yoga practice Willing able provide inform consent demonstrate pass screen tool question include Short Portable Mental Status Questionnaire Medical clearance Willing drive study site Active cancer Undergoing radiation therapy chemotherapy Medical condition would prohibit safe implementation yoga practice ( e.g. , vertigo , compromise mental status ) Active yoga practice &lt; 3 month Currently undergo phase I complete decongestive therapy ( CDT ) Inability complete study form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>